Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

Por Friedman, Gregory K., Langford, Catherine P., Coleman, Jennifer M., Cassady, Kevin A., Parker, Jacqueline N., Markert, James M., Gillespie, G. Yancey
Publicado no J Neurooncol (2009)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()

Por Waters, Alicia M., Stafman, Laura L., Garner, Evan F., Mruthyunjayappa, Smitha, Stewart, Jerry E., Friedman, Gregory K., Coleman, Jennifer M., Markert, James M., Gillespie, G. Yancey, Beierle, Elizabeth A.
Publicado no Transl Oncol (2016)

Posttranscriptional Control of Type I Interferon Genes by KSRP in the Innate Immune Response against Viral Infection

Por Lin, Wei-Jye, Zheng, Xiaojia, Lin, Chen-Chung, Tsao, Jun, Zhu, Xiaolin, Cody, James J., Coleman, Jennifer M., Gherzi, Roberto, Luo, Ming, Townes, Tim M., Parker, Jacqueline N., Chen, Ching-Yi
Publicado em 2011

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma

Por Gillory, Lauren A., Megison, Michael L., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Nabers, Hugh C., Waters, Alicia M., Kelly, Virginia, Coleman, Jennifer M., Markert, James M., Gillespie, G. Yancey, Friedman, Gregory K., Beierle, Elizabeth A.
Publicado em 2013

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors

Por Megison, Michael L., Gillory, Lauren A., Stewart, Jerry E., Nabers, Hugh C., Mroczek-Musulman, Elizabeth, Waters, Alicia M., Coleman, Jennifer M., Kelly, Virginia, Markert, James M., Gillespie, G. Yancey, Friedman, Gregory K., Beierle, Elizabeth A.
Publicado em 2014

Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12

Por Markert, James M., Cody, James J., Parker, Jacqueline N., Coleman, Jennifer M., Price, Kathleen H., Kern, Earl R., Quenelle, Debra C., Lakeman, Alfred D., Schoeb, Trenton R., Palmer, Cheryl A., Cartner, Samuel C., Gillespie, G. Yancey, Whitley, Richard J.
Publicado em 2012

Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates

Por Roth, Justin C., Cassady, Kevin A., Cody, James J., Parker, Jackie N., Price, Kathleen H., Coleman, Jennifer M., Peggins, James O., Noker, Patricia E., Powers, Nicholas W., Grimes, Sheila D., Carroll, Steven L., Gillespie, G. Yancey, Whitley, Richard J., Markert, James M.
Publicado em 2014

A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses

Por Markert, James M, Razdan, Shantanu N, Kuo, Hui-Chien, Cantor, Alan, Knoll, Anette, Karrasch, Matthias, Nabors, L Burt, Markiewicz, Michael, Agee, Bonita S, Coleman, Jennifer M, Lakeman, Alfred D, Palmer, Cheryl A, Parker, Jacqueline N, Whitley, Richard J, Weichselbaum, Ralph R, Fiveash, John B, Gillespie, G Yancey
Publicado em 2014